You are here

Article Text

Article menu
Download PDFPDF
Mailbox
Thermochemotherapy in hereditary retinoblastoma
  1. R Murthy,
  2. S G Honavar,
  3. M Naik,
  4. V A P Reddy
  1. Ocular Oncology Service, LV Prasad Eye Institute, Hyderabad, India
  1. Correspondence to: Santosh G Honavar MD, Ocular Oncology Service, LV Prasad Eye Institute, LV Prasad Marg, Banjara Hills, Hyderabad 500 034, India; honavarlvpeye.stph.net

https://doi.org/10.1136/bjo.87.11.1432

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Schueler and associates describe their experience with thermochemotherapy (TCT) in bilateral retinoblastoma.1 The reported results of transpupillary thermotherapy used in combination with chemotherapy are encouraging, with 86–96% tumour control.2,3 In the current series, however, local recurrence occurred in 38%.

    The dosage of carboplatin used in the current series was 10 mg/kg body weight, which is lower than the standard dosage of …

    View Full Text